Linzess

Generic name: Linaclotide
Drug class: Guanylate cyclase-C agonists

Usage of Linzess

Linzess is a prescription medicine used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults.

Linzess is also used to treat functional constipation (FC) in children and adolescents 6 to 17 years of age.

Linzess contains linaclotide which belongs to the class of drugs called guanylate cyclase-C agonists. The guanylate cyclase type-C (GC-C) receptor is located on the luminal surface of the intestine. Linaclotide works to treat IBS-C, CIC, and FC by stimulating the GC-C receptor to increase fluid secretion, which softens stools and stimulates bowel movements.

Linzess side effects

Get emergency medical help if you have signs of an allergic reaction to Linzess: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using Linzess and call your doctor at once if you have:

  • severe or ongoing diarrhea; or
  • diarrhea with dizziness or a light-headed feeling (like you might pass out).
  • Common Linzess side effects may include:

  • diarrhea;
  • stomach pain;
  • gas; or
  • bloating or full feeling in your stomach.
  • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Linzess

    You should not use Linzess:

  • if you are allergic to linaclotide, or
  • if you have a blockage in your intestines (bowel obstruction).
  • It is not known if this medicine is safe and effective in children less than 6 years of age with functional constipation, or in children less than 18 years of age with IBS-C.

    Linzess should not be given to a child younger than 2 years of age. Linaclotide can cause severe diarrhea and fatal dehydration in children who are younger than 2 years of age.

    Tell your doctor if you are pregnant or breastfeeding.

    Relate drugs

    How to use Linzess

    Usual Adult Dose for Irritable Bowel Syndrome with Constipation (IBS-C):

    290 mcg orally once a day Use: Treatment of irritable bowel syndrome with constipation (IBS-C)

    Usual Adult Dose for Chronic Idiopathic Constipation (CIC):

    145 mcg orally once a day Use: Treatment of chronic idiopathic constipation (CIC)

    Usual Pediatric Dose for Functional Constipation (FC):

    72 mcg orally once a day

    Use: Treatment of functional constipation (FC) in pediatric patients 6 to 17 years of age.

    Warnings

    You should not use Linzess if you have a blockage in your intestines.

    Take Linzess in the morning on an empty stomach, at least 30 minutes before your first meal. Do not crush, chew, break, or open a capsule. Swallow it whole.

    Stop using this medicine and call your doctor at once if you have severe or ongoing diarrhea, severe stomach pain, or black, bloody, or tarry stools.

    What other drugs will affect Linzess

    Other drugs may interact with linaclotide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords